TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | 7 | 1 | 4 | -9 | -32 | -5 |
| S | %wins | 67 | 67 | 33 | 33 | 67 | 100 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/1/04 17:59 | 3/1/04 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Taylor Clive R | CA | D | S.d | -273 | 2.73 | 0 | -100 | -84 | 19 | D | 27 | 365 | 65 | 6 | 4 | 18 | 12 | 10 | -3 | -3 | -19 | -40 | -51 | -53 | |
9/25/03 17:33 | 9/23/03 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Taylor Clive R | CA | D | S | -86 | 2.35 | 1 | -37 | -66 | 19 | D | 104 | 376 | 328 | 66 | 27 | 16 | 22 | 6 | -6 | -2 | 1 | 15 | -2 | -29 | |
9/17/03 18:22 | 9/15/03 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Taylor Clive R | CA | D | S.m | -42 | 1.80 | 0 | -23 | -55 | 19 | D | 48 | 205 | 252 | 10 | 27 | 12 | 2 | -8 | 7 | 26 | 20 | 37 | 26 | -15 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |